Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Data ReadoutpositiveForalumabPositive

AI Analysis

Summary

Tiziana Life Sciences reported a reduction in brain inflammation in the third Multiple System Atrophy patient treated with intranasal Foralumab. The positive clinical data demonstrates continued progress in the development program for this neurodegenerative indication.

Clinical Trial Data

Patients

Outcome Details

Reduction in brain inflammation observed in third Multiple System Atrophy patient treated with intranasal Foralumab

Importance:6/10

Sentiment:

0.70

clinical-dataneurodegenerative-diseaseintranasal-deliverypositive-results

Related Companies

$TLSA

Read the original article

Published by yahoo_finance on July 31, 2026 11:00 AM

Read Original